This study investigates the effects of a specific chemotherapy sequence on pancreatic adenocarcinoma. The purpose of this study is to understand how this treatment affects the condition in participants.
The study evaluates the safety and effectiveness of the chemotherapy sequence. It looks at how well participants tolerate the treatment and how it impacts their condition over time.
- Who can participate: Adults aged 18 and older with pancreatic adenocarcinoma may participate. Key factors include a specific performance status and adequate organ function.
- Study details: Participants will receive a sequence of chemotherapy treatments.